High-Dose Rate Brachytherapy
Sponsors
Rutgers, The State University of New Jersey, National Cancer Institute (NCI), Sidney Kimmel Cancer Center at Thomas Jefferson University, Oslo University Hospital, Jonsson Comprehensive Cancer Center
Conditions
Advanced Cervical AdenocarcinomaAdvanced Cervical Adenosquamous CarcinomaAdvanced Cervical Squamous Cell CarcinomaAdvanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell CarcinomaCervical AdenocarcinomaCervical Adenosquamous Carcinoma
Phase 1
Phase 2
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
CompletedNCT02526498
Start: 2015-07-15End: 2021-03-31Updated: 2023-05-15
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
Active, not recruitingNCT04253483
Start: 2019-07-17End: 2027-09-01Updated: 2025-09-17
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
RecruitingNCT07276360
Start: 2026-03-11End: 2029-01-02Target: 278Updated: 2026-03-27
Unknown Phase
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
CompletedNCT02899221
Start: 2017-03-21End: 2025-10-29Updated: 2026-02-20
Experiences With HDR-brachytherapy in Norway
CompletedNCT03162523
Start: 2004-01-31End: 2016-10-15Updated: 2017-05-25
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
WithdrawnNCT04399824
Start: 2020-04-03End: 2020-04-03Updated: 2020-11-06
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
RecruitingNCT04725903
Start: 2021-02-01End: 2027-12-31Target: 30Updated: 2026-02-17
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
RecruitingNCT04945642
Start: 2021-08-20End: 2027-07-01Target: 52Updated: 2025-07-15
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Not yet recruitingNCT07468903
Start: 2026-04-04End: 2032-04-04Target: 45Updated: 2026-03-19